{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:40:58Z","timestamp":1791196858103,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T00:00:00Z","timestamp":1234483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s11095-009-9841-2","type":"journal-article","created":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T20:28:25Z","timestamp":1234470505000},"page":"1324-1331","source":"Crossref","is-referenced-by-count":130,"title":["Biodegradable Nanoparticles Improve Oral Bioavailability of Amphotericin B and Show Reduced Nephrotoxicity Compared to Intravenous Fungizone\u00ae"],"prefix":"10.1007","volume":"26","author":[{"given":"J. L.","family":"Italia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. N. V.","family":"Ravi Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,13]]},"reference":[{"key":"9841_CR1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00001432-200208000-00001","volume":"15","author":"C. Junhass","year":"2002","unstructured":"C. Junhass, and K. A. Marr. Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture? Curr. Opin. Infect. Dis. 15:347\u2013353 (2002).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"9841_CR2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s10096-002-0699-z","volume":"21","author":"D. P. Kontoyiannis","year":"2002","unstructured":"D. P. Kontoyiannis, and G. P. Bodey. Invasive aspergillosis in 2002: an update. Eur. J. Clin. Microbiol. Infect. Dis. 21:162\u2013172 (2002) doi: 10.1007\/s10096-002-0699-z .","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"9841_CR3","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/clinids\/14.Supplement_1.S154","volume":"14","author":"R. D. Meyer","year":"1992","unstructured":"R. D. Meyer. Current role of therapy with amphotericin B. Clin. Infect. Dis. 14:S154\u2013S160 (1992).","journal-title":"Clin. Infect. Dis."},{"key":"9841_CR4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2710.1993.tb00605.x","volume":"18","author":"C. Gates","year":"1993","unstructured":"C. Gates, and R. J. Pinney. Amphotericin B and its delivery by liposomal and lipid formulations. J. Clin. Pharm. Ther. 18:147\u2013153 (1993) doi: 10.1111\/j.1365-2710.1993.tb00605.x .","journal-title":"J. Clin. Pharm. Ther."},{"key":"9841_CR5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0035-9203(96)90271-0","volume":"90","author":"C. P. Thakur","year":"1996","unstructured":"C. P. Thakur, A. K. Pandey, G. P. Sinha, S. Roy, K. Behbehani, and P. Oilliaro. Comparison of three treatment regimens with liposomal amphotericin B (Ambisome) for visceral leishmaniasis in India: a randomized dose finding study. Trans. R. Soc. Trop. Med. Hyg. 90:319\u2013322 (1996) doi: 10.1016\/S0035-9203(96)90271-0 .","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"9841_CR6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00001432-200212000-00007","volume":"15","author":"S. Sundar","year":"2002","unstructured":"S. Sundar, and M. Rai. Advances in the treatment of leishmaniasis. Curr. Opin. Infect. Dis. 15:593\u2013598 (2002).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"9841_CR7","first-page":"93","volume":"5","author":"S. Arikan","year":"2001","unstructured":"S. Arikan, and J. H. Rex. Lipid-based antifungal agents: current status. Curr. Pharm. Des. 5:93\u2013415 (2001).","journal-title":"Curr. Pharm. Des."},{"key":"9841_CR8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","volume":"12","author":"H. A. Gallis","year":"1990","unstructured":"H. A. Gallis, R. H. Drew, and W. W. Pickard. Amphotericin B: 30\u00a0years of clinical experience. Rev. Infect. Dis. 12:308\u2013329 (1990).","journal-title":"Rev. Infect. Dis."},{"key":"9841_CR9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-5173(97)00311-6","volume":"160","author":"R. H. M\u00fcller","year":"1998","unstructured":"R. H. M\u00fcller, and K. Peters. Nanosuspensions for the formulation of poorly soluble drugs. I. Preparation by a size-reduction technique. Int. J. Pharm. 160:229\u2013237 (1998) doi: 10.1016\/S0378-5173(97)00311-6 .","journal-title":"Int. J. Pharm."},{"key":"9841_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(02)00686-5","volume":"254","author":"O. Kayser","year":"2003","unstructured":"O. Kayser, C. Olbrich, V. Yardley, A. F. Kiderlen, and S. L. Croft. Formulation of amphotericin B as nanosuspension for oral administration. Int. J. Pharm. 254:73\u201375 (2003) doi: 10.1016\/S0378-5173(02)00686-5 .","journal-title":"Int. J. Pharm."},{"key":"9841_CR11","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1128\/AAC.47.10.3339-3342.2003","volume":"47","author":"V. Risovic","year":"2003","unstructured":"V. Risovic, M. Boyd, E. Choo, and K. M. Wasan. Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats. Antimicrob. Agents Chemother. 47:3339\u20133342 (2003) doi: 10.1128\/AAC.47.10.3339-3342.2003 .","journal-title":"Antimicrob. Agents Chemother."},{"key":"9841_CR12","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/AAC.44.9.2356-2360.2000","volume":"44","author":"R. Santangelo","year":"2000","unstructured":"R. Santangelo, P. Paderu, G. Delmas, Z. W. Chen, R. Mannino, L. Zarif, and D. S. Perlin. Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrob. Agents Chemother. 44:2356\u20132360 (2000) doi: 10.1128\/AAC.44.9.2356-2360.2000 .","journal-title":"Antimicrob. Agents Chemother."},{"key":"9841_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11745-007-3142-5","volume":"43","author":"A. K. Meena","year":"2008","unstructured":"A. K. Meena, D. Venkat Ratnam, G. Chandraiah, D. D. Ankola, P. Rama Rao, and M. N. V. Ravi Kumar. Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure\u00ae in treating hyperlipidemia. Lipids. 43:231\u2013241 (2008) doi: 10.1007\/s11745-007-3142-5 .","journal-title":"Lipids"},{"key":"9841_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0928-0987(97)10007-0","volume":"6","author":"S. McClean","year":"1998","unstructured":"S. McClean, E. Prosser, E. Meehan, D. O\u2019Malley, N. Clarke, Z. Ramtoola, and D. Brayden. Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia. Eur. J. Pharm. Sci. 6:153\u2013163 (1998) doi: 10.1016\/S0928-0987(97)10007-0 .","journal-title":"Eur. J. Pharm. Sci."},{"key":"9841_CR15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2007.01.016","volume":"119","author":"G. Mittal","year":"2007","unstructured":"G. Mittal, D. K. Sahana, V. Bhardawaj, and M. N. V. R. Kumar. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J. Control Release. 119:77\u201383 (2007) doi: 10.1016\/j.jconrel.2007.01.016 .","journal-title":"J. Control Release"},{"key":"9841_CR16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejps.2004.09.011","volume":"24","author":"U. Bilati","year":"2005","unstructured":"U. Bilati, E. Allemann, and E. Doelker. Development of a nonoprecipitation method intended for entrapment of hydrophilic drugs into nanoparticles. Eur. J. Pharm. Sci. 24:68\u201369 (2005) doi: 10.1016\/j.ejps.2004.09.011 .","journal-title":"Eur. J. Pharm. Sci."},{"key":"9841_CR17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijpharm.2006.01.041","volume":"314","author":"K. Dillen","year":"2006","unstructured":"K. Dillen, J. Vanderwoot, G. V. D. Mooter, and A. Ludwig. Evaluation of ciprofloxacin loaded Eudragit\u00ae RS100 or RL100\/PLGA nanoparticles. Int. J. Pharm. 314:72\u201382 (2006) doi: 10.1016\/j.ijpharm.2006.01.041 .","journal-title":"Int. J. Pharm."},{"key":"9841_CR18","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/jps.21158","volume":"97","author":"D. K. Sahana","year":"2008","unstructured":"D. K. Sahana, G. Mittal, V. Bhardwaj, and M. N. V. Ravi Kumar. PLGA nanoparticles for oral delivery of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J. Pharm. Sci. 97:1530\u20131542 (2008) doi: 10.1002\/jps.21158 .","journal-title":"J. Pharm. Sci."},{"key":"9841_CR19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1163\/156856297X00380","volume":"8","author":"S. R. Jameela","year":"1997","unstructured":"S. R. Jameela, N. Suma, and A. Jayakrishna. Protein release from poly (\u03b5-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study. J. Biomater. Sci. Polym. Ed. 8:457\u2013466 (1997) doi: 10.1163\/156856297X00380 .","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"9841_CR20","first-page":"125","volume":"13","author":"C. Paulo","year":"2000","unstructured":"C. Paulo, and M. S. L. Jose. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13:125 (2000).","journal-title":"Eur. J. Pharm. Sci."},{"key":"9841_CR21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11095-005-8418-y","volume":"23","author":"S. Hariharan","year":"2006","unstructured":"S. Hariharan, V. Bhardwaj, I. Bala, J. Sitterberg, U. Bakowsky, and M. N. V. Ravi Kumar. Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy. Pharm. Res. 23:184\u2013195 (2006) doi: 10.1007\/s11095-005-8418-y .","journal-title":"Pharm. Res."},{"key":"9841_CR22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jconrel.2007.02.004","volume":"119","author":"J. L. Italia","year":"2007","unstructured":"J. L. Italia, D. K. Bhatt, V. Bhardwaj, K. Tikoo, and M. N. V. Ravi Kumar. PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral. J. Control Release. 119:197\u2013206 (2007) doi: 10.1016\/j.jconrel.2007.02.004 .","journal-title":"J. Control Release"},{"key":"9841_CR23","first-page":"484","volume-title":"Pharmacokinetic parameters of important drugs. Handbook of Basic Pharmacokinetic","author":"A. W. Ritschel","year":"1998","unstructured":"A. W. Ritschel, and G. L. Kearns, Pharmacokinetic parameters of important drugs. Handbook of Basic Pharmacokinetic. American Pharmaceutical Association, Washington, p 484 (1998)"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-009-9841-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-009-9841-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-009-9841-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:43:13Z","timestamp":1559367793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-009-9841-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,13]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["9841"],"URL":"https:\/\/doi.org\/10.1007\/s11095-009-9841-2","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,13]]}}}